A Multilaboratory, Multicountry Study To Determine MIC Quality Control Ranges for Phenotypic Drug Susceptibility Testing of Selected First-Line Antituberculosis Drugs, Second-Line Injectables, Fluoroquinolones, Clofazimine, and Linezolid. - Wikidata - wikimedia - TriplyDB

A Multilaboratory, Multicountry Study To Determine MIC Quality Control Ranges for Phenotypic Drug Susceptibility Testing of Selected First-Line Antituberculosis Drugs, Second-Line Injectables, Fluoroquinolones, Clofazimine, and Linezolid.

A Multilaboratory, Multicountry Study To Determine MIC Quality Control Ranges for Phenotypic Drug Susceptibility Testing of Selected First-Line Antituberculosis Drugs, Second-Line Injectables, Fluoroquinolones, Clofazimine, and Linezolid.

http://www.wikidata.org/entity/Q37434301

about

Ethambutol Partitioning in Tuberculous Pulmonary Lesions Explains Its Clinical Efficacy.Clofazimine encapsulation in nanoporous silica particles for the oral treatment of antibiotic-resistant Mycobacterium tuberculosis infections.Whole transcriptome and genomic analysis of extensively drug-resistant Mycobacterium tuberculosis clinical isolates identifies downregulation of ethA as a mechanism of ethionamide resistance.Validating a 14-Drug Microtiter Plate Containing Bedaquiline and Delamanid for Large-Scale Research Susceptibility Testing of Mycobacterium tuberculosis

P2860

Q40139981-139F55BB-4FED-4A28-90A3-5974398CB802 Q40280093-C150FD27-9774-44DE-8438-9654F01B645C Q41989379-4A464228-1A98-41C7-8C95-0A5F96A87B99 Q57922209-BF2B5BDB-815A-4963-9150-DCB91213857F

P2860

A Multilaboratory, Multicountry Study To Determine MIC Quality Control Ranges for Phenotypic Drug Susceptibility Testing of Selected First-Line Antituberculosis Drugs, Second-Line Injectables, Fluoroquinolones, Clofazimine, and Linezolid.

http://www.wikidata.org/entity/Q37434301

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 21 September 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

A Multilaboratory, Multicountr ...... s, Clofazimine, and Linezolid.

@en

A Multilaboratory, Multicountr ...... s, Clofazimine, and Linezolid.

@nl

type

label

A Multilaboratory, Multicountr ...... s, Clofazimine, and Linezolid.

@en

A Multilaboratory, Multicountr ...... s, Clofazimine, and Linezolid.

@nl

prefLabel

A Multilaboratory, Multicountr ...... s, Clofazimine, and Linezolid.

@en

A Multilaboratory, Multicountr ...... s, Clofazimine, and Linezolid.

@nl

P1433

Q37434301-02F31A00-BC5B-4E2E-8D59-06AA86206CC2

P1476

Q37434301-20709749-437A-49F1-9520-237D3DB62306

P2093

Q37434301-14D5BF3F-D047-4D7D-BADA-74B2C5A1B891

Q37434301-173298A8-532A-45FF-85BD-5DDCD6CEC2C3

Q37434301-181D462E-A6EF-4CC0-A043-475367E55E82

Q37434301-40FCE98F-F70B-46EE-B78C-7E5617A6036D

Q37434301-4B9DF064-642D-4737-8F66-697C05466116

Q37434301-76FB3BFE-9DF7-4FDC-AC0E-0E83484F1F1B

Q37434301-DADD8599-0B04-4102-9E87-1792A911C999

Q37434301-EDA2870F-5BFB-4F32-B120-9F60227B6DD9

P2860

Q37434301-2A04435D-F283-418C-BC27-155FC46FE17C

Q37434301-44D156E9-B9DC-4D8A-8C5E-2D34C573FCF4

Q37434301-4E728B8A-FAD9-481F-9322-BA6BB0FC707B

Q37434301-63D88FAF-E768-4305-B7B4-22C16645B771

Q37434301-673E019A-0F21-405D-8B0F-D70C1F95CD42

Q37434301-80B6016A-B753-4CB1-896C-AC2AF8242AB6

Q37434301-8A9C2925-8467-4977-A361-A4C0F8FB07C4

Q37434301-937C917E-DFC7-411A-BDF5-06559D884183

Q37434301-94BC7F39-F9ED-4231-953A-0B8F43FFE574

Q37434301-9D0326B5-F434-4EF9-B59A-609F787563B3

P304

Q37434301-70B573D2-0759-4A9F-AB8C-996B13A1CD8F

P31

Q37434301-218B8FCB-EBBA-4586-AAE0-523168F5B78F

P356

Q37434301-348D3A7B-1B13-4977-B69D-BF323A6BB7BA

P407

Q37434301-B6B16134-8E83-46D9-98BF-6A57937FD251

P433

Q37434301-AE2A1D45-F552-4791-9632-D92B4B6A864D

P478

Q37434301-DE334F89-3778-4541-9344-9688A2413C32

P50

Q37434301-23D5B282-9D38-472F-BBA9-8B71052A32EE

P577

Q37434301-DB2CF15A-EF09-416D-8BE6-43482622EA2F

P698

Q37434301-D41B3404-8D04-456B-8DC1-536AC399E583

P921

Q37434301-FDB9C1A2-74B9-4846-AEB8-2E3FEE20FC2E

P932

Q37434301-378BAE7E-056C-41E9-899A-D9F066628994

P356

P1433

Journal of Clinical Microbiology

P1476

A Multilaboratory, Multicountr ...... s, Clofazimine, and Linezolid.

@en

P2093

Amour Venter

http://www.w3.org/2001/XMLSchema#string

Beverly Metchock

http://www.w3.org/2001/XMLSchema#string

Daniela M Cirillo

http://www.w3.org/2001/XMLSchema#string

Gaby E Pfyffer

http://www.w3.org/2001/XMLSchema#string

Koné Kaniga

http://www.w3.org/2001/XMLSchema#string

Nacer Lounis

http://www.w3.org/2001/XMLSchema#string

Nazir A Ismail

http://www.w3.org/2001/XMLSchema#string

Sven Hoffner

http://www.w3.org/2001/XMLSchema#string

P2860

Wild-type MIC distributions of four fluoroquinolones active against Mycobacterium tuberculosis in relation to current critical concentrations and available pharmacokinetic and pharmacodynamic data.

Pharmacodynamic evaluation of the intracellular activities of antibiotics against Staphylococcus aureus in a model of THP-1 macrophages.

Setting and revising antibacterial susceptibility breakpoints.

Population pharmacokinetics and pharmacodynamics of ofloxacin in South African patients with multidrug-resistant tuberculosis

A Multilaboratory, Multicountry Study To Determine Bedaquiline MIC Quality Control Ranges for Phenotypic Drug Susceptibility Testing.

A new rapid and simple colorimetric method to detect pyrazinamide resistance in Mycobacterium tuberculosis using nicotinamide.

Uptake and intracellular activity of moxifloxacin in human neutrophils and tissue-cultured epithelial cells

Moxifloxacin pharmacokinetics/pharmacodynamics and optimal dose and susceptibility breakpoint identification for treatment of disseminated Mycobacterium avium infection.

Ethambutol optimal clinical dose and susceptibility breakpoint identification by use of a novel pharmacokinetic-pharmacodynamic model of disseminated intracellular Mycobacterium avium.

P304

2963-2968

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JCM.01138-16

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

54

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-09-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27654338

http://www.w3.org/2001/XMLSchema#string

P921

quality control

P932

5121386

http://www.w3.org/2001/XMLSchema#string